Iovance Biotherapeutics Sees FY2026 Sales $350.000M-$370.000M vs $370.477M Est

Benzinga Newsdesk www.benzinga.com Positive 73.3%

Neg 0% Neu 0% Pos 73.3%

Iovance Biotherapeutics (NASDAQ:IOVA) sees FY2026 sales of $350.000 million-$370.000 million vs $370.477 million analyst estimate.